Form D · Other Health Care
Cadence RX, Inc.
Tampa, FL · CIK 0001839145
Offering snapshot reported Jan 7, 2021 · SEC filing
- Reported sold
- $2.5M Offering amount: $2.5M
- Investors reported
- 2 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Apr 27, 2020 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jan 7, 2021 | Initial | $2,500,000 | No comparison | 2 | SEC filing |
Offering details
- Securities
- Equity, Other
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-385510
Preferred Stock can convert to Common Stock.
Source: Form D, filed Jan 7, 2021. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Artemis Emslie | Director, Executive |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
5440 Mariner St
Tampa, FL, 33609
Tampa, FL, 33609